Chiari MalformationSymptoms, Doctors, Treatments, Advances & More
Chiari Malformation Overview
Learn About Chiari Malformation
Johns Hopkins Outpatient Center
Dr. Mark Luciano is the director of the Johns Hopkins Hydrocephalus and Cerebral Fluid Center. A renowned leader in treating hydrocephalus, Dr. Luciano is distinguished both nationally and internationally for his research and educational and clinical work in neuroendoscopy. Dr. Luciano treats adults with hydrocephalus, pseudotumor cerebri, intracranial hypotension, Chiari malformations, and cerebral and spinal cysts. He has significant expertise treating children and adults with cerebrospinal fluid leaks and congenital disorders. Among his accomplishments in neuroscience research and biomedical engineering are his investigation of the cerebrovascular response to hydrocephalus and the invention of a unique device for control of intracranial pressure (ICP) pulsatility to increase blood flow. His National Institutes of Health-funded studies have explored prolonged compression and hypoxia in the brain as a result of hydrocephalus, as well as the interaction between cerebrospinal fluid and vascular systems. Dr. Luciano is rated as an Elite provider by MediFind in the treatment of Chiari Malformation. He is also highly rated in 25 other conditions, according to our data. His clinical expertise encompasses Hydrocephalus, Normal Pressure Hydrocephalus, Increased Intracranial Pressure, Posterior Fossa Decompression, and Stent Placement. Dr. Luciano is board certified in American Board Of Neurological Surgery.
C. S. Mott Children's Hospital
Hugh Garton is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Garton is rated as an Elite provider by MediFind in the treatment of Chiari Malformation. He is also highly rated in 72 other conditions, according to our data. His clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 1, Chiari Malformation Type 2, Posterior Fossa Decompression, and Gamma Knife Radiosurgery. Dr. Garton is board certified in Neurological Surgery.
C. S. Mott Children's Hospital
Karin Muraszko, M.D., grew up in New Jersey and received her undergraduate degree from Yale University. She then continued to Columbia University in New York where she received her medical degree and completed her residency training in Neurological Surgery and completed fellowships in pediatric neurosurgery.Following her training at Columbia, Dr. Muraszko was a researcher at the National Institutes for Health for two years before joining the team at the University of Michigan. From 2005 to 2022, Dr. Muraszko served as the head the Department of Neurosurgery at the University of Michigan. She was the first woman to chair an academic neurosurgery department in the United States.Dr. Muraszko specializes in pediatric neurosurgery. She is board certified by the American Board of Neurological Surgeons, and is a member of the American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS) along with several pediatric professional associations. Her research interests include Immunotoxin therapy for brain tumors, the biology of brain tumors, Chiari malformations, craniofacial anomalies, congenital anomalies of the brain and spine and hydrocephalus.Dr. Muraszko lives in Ann Arbor with her husband and two children. Dr. Muraszko is rated as an Elite provider by MediFind in the treatment of Chiari Malformation. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Chiari Malformation, Chiari Malformation Type 2, Tethered Cord Syndrome, Posterior Fossa Decompression, and Bone Graft. Dr. Muraszko is board certified in Neurological Surgery and Pediatric Neurosurgery.
Summary: This study will be conducted in Hacettepe University Faculty of Medicine Neurosurgery Department and Hacettepe University Faculty of Physical Therapy and Rehabilitation. The study was designed as a randomized controlled trial. At the beginning of the study, demographic data and characteristics of the cases will be recorded. Patients will be evaluated in three different periods throughout the study...
Published Date: May 10, 2022
Published By: Genetic and Rare Diseases Informnation Center


